Caliway Biopharmaceuticals Co., Ltd. (6919)
TWSE
Closed
Dec 2, 2024
Day's Range
592.0052 wk Range
240.50Overview - 6919 - Caliway Biopharmaceuticals Co., Ltd.
Key Statistics
Valuation
Enterprise Value
39.15B
P/E (Trailing)
‪-155.07‬
Price / Sales (TTM)
‪1,093.08‬
Price / Book
‪8.72‬
EV / EBITDA
‪-85.10‬
Profitability
Gross Margin
‪68.83%‬
Profit Margin
‪70.55%‬
Operating Margin
‪-1,253.35%‬
Return on Assets
‪-12.76%‬
Return on Equity
‪-13.05%‬
Ownership
Shares Outstanding
153.43M
Market Cap - 6919 - Caliway Biopharmaceuticals Co., Ltd.
Peers - 6919 - Caliway Biopharmaceuticals Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on TWSE.
- 6919TWSECaliway Biopharmaceuticals Co., Ltd.42.55BMarket Cap—52-week change-155.08P/E (Trailing)‪70.55%‬Profit Margin
- 6949TWSEPell Bio-Med Technology Co., Ltd.80.61BMarket Cap+68.42%52-week change-170.12P/E (Trailing)‪-13.97%‬Profit Margin
- 6696TWSELin BioScience, Inc.77.69BMarket Cap+83.89%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 6586TWSECho Pharma Inc.24.18BMarket Cap+66.02%52-week change—P/E (Trailing)‪74.49%‬Profit Margin
- 4743TWSEOneness Biotech Co., Ltd.23.97BMarket Cap-48.00%52-week change384.62P/E (Trailing)‪39.54%‬Profit Margin
- 4728TWSESunmax Biotechnology Co., Ltd.21.54BMarket Cap-4.17%52-week change29.76P/E (Trailing)‪35.54%‬Profit Margin
- 7827TWSEHanchorBio Inc.19.68BMarket Cap+42.70%52-week change—P/E (Trailing)‪-159.37%‬Profit Margin
Profile Summary - 6919 - Caliway Biopharmaceuticals Co., Ltd.
About
Caliway Biopharmaceuticals Co., Ltd. is a company specializing in the development and commercialization of innovative pharmaceutical products. Its primary function is to advance medical treatments through its robust pipeline of therapies, focusing on unmet medical needs in areas such as dermatology, neurology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
